Amgen rips off its $10B M&A cap, looking for deals “large and small”
You can put Amgen $AMGN on the list of biotech’s big game hunters.
In their quarterly meeting with analysts Thursday, Amgen CEO Bob Bradway said …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
